
BioLife Solutions BLFS
€ 30.38
0.74%
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
47.8 M |
Marktkapitalisierung |
$ 1.67 B |
EBITDA (LTM) |
$ -13.4 M |
P/E (LTM) |
54.73 |
P/S (LTM) |
14.8 |
EPS (LTM) |
0.62 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
$ 76.17 | 0.02 % | $ 15.2 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 184.53 | 1.51 % | $ 10.6 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Haemonetics Corporation
HAE
|
$ 90.8 | 0.46 % | $ 4.28 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.66 | 0.43 % | $ 296 M | Nasdaq Global Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AtriCure
ATRC
|
$ 44.3 | 1.86 % | $ 2.12 B | Nasdaq Global Market,SPB | ||
|
ICU Medical
ICUI
|
$ 182.98 | 0.22 % | $ 4.51 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
AngioDynamics
ANGO
|
$ 15.85 | 1.21 % | $ 658 M | Nasdaq Global Select Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 4.63 | 0.21 % | $ 49.1 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 126.44 | 2.66 % | $ 4.05 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 44.54 | 0.02 % | $ 3 B | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 224.46 | 0.22 % | $ 32.7 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 12.27 | 1.96 % | $ 253 M | NYSE American | ||
|
Repligen Corporation
RGEN
|
$ 166.83 | 0.01 % | $ 9.38 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 26.73 | 0.37 % | $ 13.7 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 67.02 | 0.17 % | $ 220 B | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 394.51 | 0.05 % | $ 141 B | Nasdaq Global Select Market,SPB | ||
|
STERIS plc
STE
|
$ 233.28 | 0.24 % | $ 22.9 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 9.97 | 0.3 % | $ 84.6 K | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 349.42 | 0.94 % | $ 25.3 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 90.76 | 0.29 % | $ 5.37 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.5 | 5.33 % | $ 41 M | NYSE American | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.59 | 0.09 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 74.25 | 1.05 % | $ 36.6 B | NYSE | ||
|
Envista Holdings Corporation
NVST
|
$ 28.07 | 0.04 % | $ 4.72 B | NYSE | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.55 | 0.11 % | $ 71 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 26.18 | 3.36 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.38 | 2.86 % | $ 126 M | NYSE American | ||
|
Repro Med Systems
KRMD
|
$ 3.4 | 2.26 % | $ 157 M | Nasdaq Capital Market | ||
|
OraSure Technologies
OSUR
|
$ 3.84 | 7.2 % | $ 282 M | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 137.17 | 0.1 % | $ 6.12 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 82.38 | 0.55 % | $ 1.86 B | Nasdaq Global Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 183.4 | 0.79 % | $ 52.8 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 2.99 % | $ 20.7 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 71.0 | 0.14 % | $ 230 M | Nasdaq Global Select Market |